Emiac Technologies IPO Day 4: GMP ₹0, Subscription 35.0x
As Emiac Technologies’ Small and Medium Enterprise (SME) IPO on the BSE enters its fourth day of subscription, the market is observing a significant surge in overall subscription levels. The IPO, which opened on March 27, 2026, and is set to close on April 8, 2026, has seen robust demand, particularly driven by the Non-Institutional Investor (NII) category. With an issue price of ₹93 per share, investors are keenly watching the subscription figures to gauge potential listing gains.
| Date | GMP | Est. Listing |
|---|---|---|
| 01 Apr | ₹0 | ₹93 |
| 23 Mar | ₹0 | ₹93 |
Subscription Status
The subscription figures for Emiac Technologies’ IPO on Day 4 present an encouraging picture. The overall subscription has reached an impressive 35 times the offered shares. This strong demand is largely fueled by the Non-Institutional Investor (NII) category, which has been subscribed 0 times. The Qualified Institutional Buyer (QIB) and Retail individual investor categories are also showing healthy interest, though their specific subscription multiples are not yet available for Day 4. A total subscription of 35x indicates substantial investor confidence in the company’s prospects.
| Category | Subscription | Progress |
|---|---|---|
| Retail | 0.00x | |
| NII / HNI | 0.00x | |
| QIB | 0.00x | |
| Total | 35.00x |
GMP Update
Regarding the Grey Market Premium (GMP), Emiac Technologies’ IPO currently stands at ₹0. This is an unchanged figure from the previous day, indicating a stable, albeit neutral, sentiment in the grey market. The expected listing price is currently pegged at the issue price of ₹93. While a zero GMP doesn’t necessarily translate to a poor listing, it suggests that the market is not currently pricing in any significant premium over the issue price based on grey market activity alone.
Should You Apply?
The decision to apply for the Emiac Technologies IPO should be based on a comprehensive analysis of both subscription data and GMP trends. The exceptionally high overall subscription, especially the strong interest from NIIs, points towards a potentially successful IPO. However, the current neutral GMP warrants careful consideration. Investors should weigh the strong subscription against the lack of a premium in the grey market. As per SEBI advisories, it is always recommended to conduct thorough due diligence and consult with registered financial advisors before making any investment decisions. The lot size for this IPO is 1200 shares.
For more detailed information and ongoing updates, please View Full Emiac Technologies IPO Details.